Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Blaser

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Blood|August 10, 2018
Making HSCs in vitro: don't forget the hemogenic endotheliumBradley W Blaser, Leonard I Zon
Best Practice & Research. Clinical Haematology|March 7, 2006
Autologous immune strategies to reduce the risk of leukemic relapse: consideration for IL-15Bradley W Blaser, Michael A Caligiuri
JCO Oncology Practice|July 16, 2025
Trends of Authors' Conflicts of Interest in Clinical Trials Published in the <i>Journal of Clinical Oncology</i>: A Large Language Model-Assisted Longitudinal StudyJiasheng Wang, Pedro C Silberman, Sayan Mullick Chowdhury, et al.
Zebrafish|September 20, 2021
An Optimized Zebrafish Nursery Feeding Regimen Improves Growth Rates and Labor CostsToi A Collins, Shelby Cabrera, Emily Teets, et al.
Scientific Reports|February 9, 2020
Quantifying Hematopoietic Stem Cell Clonal Diversity by Selecting Informative Amplicon BarcodesEmily M Teets, Charles Gregory, Jami Shaffer, et al.
Expert Opinion on Biological Therapy|March 29, 2003
New directions in natural killer cell-based immunotherapy of human cancerSherif S Farag, Todd A Fehniger, Brian Becknell, et al.
Blood|March 25, 2006
Tumor growth impedes natural-killer-cell maturation in the bone marrowJohn O Richards, Xing Chang, Bradley W Blaser, et al.
Blood|June 1, 2007
Pharmacologic inhibition of CDK4/6: mechanistic evidence for selective activity or acquired resistance in acute myeloid leukemiaLisheng Wang, Jie Wang, Bradley W Blaser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Preclinical assessment of FHIT gene replacement therapy in human leukemia using a chimeric adenovirus, Ad5/F35Flavia Pichiorri, Francesco Trapasso, Tiziana Palumbo, et al.
Leukemia Research|August 8, 2009
A novel mouse model for the aggressive variant of NK cell and T cell large granular lymphocyte leukemiaAkihiko Yokohama, Anjali Mishra, Takeki Mitsui, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Blood|August 10, 2018
Making HSCs in vitro: don't forget the hemogenic endotheliumBradley W Blaser, Leonard I Zon
Best Practice & Research. Clinical Haematology|March 7, 2006
Autologous immune strategies to reduce the risk of leukemic relapse: consideration for IL-15Bradley W Blaser, Michael A Caligiuri
JCO Oncology Practice|July 16, 2025
Trends of Authors' Conflicts of Interest in Clinical Trials Published in the <i>Journal of Clinical Oncology</i>: A Large Language Model-Assisted Longitudinal StudyJiasheng Wang, Pedro C Silberman, Sayan Mullick Chowdhury, et al.
Zebrafish|September 20, 2021
An Optimized Zebrafish Nursery Feeding Regimen Improves Growth Rates and Labor CostsToi A Collins, Shelby Cabrera, Emily Teets, et al.
Scientific Reports|February 9, 2020
Quantifying Hematopoietic Stem Cell Clonal Diversity by Selecting Informative Amplicon BarcodesEmily M Teets, Charles Gregory, Jami Shaffer, et al.
Expert Opinion on Biological Therapy|March 29, 2003
New directions in natural killer cell-based immunotherapy of human cancerSherif S Farag, Todd A Fehniger, Brian Becknell, et al.
Blood|March 25, 2006
Tumor growth impedes natural-killer-cell maturation in the bone marrowJohn O Richards, Xing Chang, Bradley W Blaser, et al.
Blood|June 1, 2007
Pharmacologic inhibition of CDK4/6: mechanistic evidence for selective activity or acquired resistance in acute myeloid leukemiaLisheng Wang, Jie Wang, Bradley W Blaser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Preclinical assessment of FHIT gene replacement therapy in human leukemia using a chimeric adenovirus, Ad5/F35Flavia Pichiorri, Francesco Trapasso, Tiziana Palumbo, et al.
Leukemia Research|August 8, 2009
A novel mouse model for the aggressive variant of NK cell and T cell large granular lymphocyte leukemiaAkihiko Yokohama, Anjali Mishra, Takeki Mitsui, et al.
Pageof 5